Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Debt Ratio: 2013-2025

Historic Debt Ratio for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to 0.26.

  • Fortress Biotech's Debt Ratio fell 36.22% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year decrease of 36.22%. This contributed to the annual value of 0.40 for FY2024, which is 10.63% up from last year.
  • Per Fortress Biotech's latest filing, its Debt Ratio stood at 0.26 for Q3 2025, which was down 15.83% from 0.31 recorded in Q2 2025.
  • Fortress Biotech's Debt Ratio's 5-year high stood at 0.46 during Q2 2024, with a 5-year trough of 0.10 in Q3 2021.
  • In the last 3 years, Fortress Biotech's Debt Ratio had a median value of 0.34 in 2023 and averaged 0.35.
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 57.13% in 2021, then spiked by 187.83% in 2022.
  • Over the past 5 years, Fortress Biotech's Debt Ratio (Quarterly) stood at 0.11 in 2021, then soared by 187.83% to 0.31 in 2022, then rose by 16.55% to 0.36 in 2023, then increased by 10.63% to 0.40 in 2024, then tumbled by 36.22% to 0.26 in 2025.
  • Its last three reported values are 0.26 in Q3 2025, 0.31 for Q2 2025, and 0.32 during Q1 2025.